Interaction between Osmotic- and Pressure-induced Water Flow in Plant Roots

Por Newman, Edward I.
Publicado em 1976

Determination of triiodothyronine concentration in human serum

Por Sterling, Kenneth, Bellabarba, Diego, Newman, Edward S., Brenner, Milton A.
Publicado em 1969

Preparation and Properties of Thyroxine-Binding Alpha Globulin (TBG)

Por Sterling, Kenneth, Hamada, Satoshi, Takemura, Yoshihiro, Brenner, Milton A., Newman, Edward S., Inada, Mitsuo
Publicado em 1971

Sequential Oral Hydroxyurea and Intravenous Cytosine Arabinoside in Refractory Childhood Acute Leukemia: A Pediatric Oncology Group Phase I Study

Por Dubowy, Ronald, Graham, Michael, Hakami, Nasrollah, Kletzel, Morris, Mahoney, Donald, Newman, Edward, Ravindranath, Yaddanapudi, Camitta, Bruce
Publicado no J Pediatr Hematol Oncol (2008)

A Phase 2 Study of Belinostat (PXD101) in Patients with Relapsed or Refractory Acute Myloid Leukemia or Patients Over 60 with Newly-Diagnosed Acute Myloid Leukemia: A California Ca...

Por Kirschbaum, Mark H., Foon, Kenneth A., Frankel, Paul, Ruel, Christopher, Pulone, Bernadette, Tuscano, Joseph M., Newman, Edward M.
Publicado em 2014

A phase I trial of oxaliplatin in combination with docetaxel in patients with advanced solid tumors

Por Iqbal, Syma, Lenz, Heinz-Josef, Gandara, David R., Shibata, Stephen I., Groshen, Susan, Synold, Timothy W., Newman, Edward M.
Publicado em 2013

CD30 downregulation, MMAE resistance, and MDR1 upregulation are all associated with resistance to brentuximab vedotin

Por Chen, Robert, Hou, Jessie, Newman, Edward, Kim, Young, Donohue, Cecile, Liu, Xueli, Thomas, Sandra H., Forman, Stephen J., Kane, Susan E.
Publicado no Mol Cancer Ther (2015)

A Phase II study of VEGF Trap (Aflibercept, NSC 724770) in Patients with MDS: A California Cancer Consortium Study

Por Kirschbaum, Mark, Frankel, Paul, Synold, Timothy W., Zain, Jasmine, Claxton, David, Tuscano, Joseph, Newman, Edward M., Gandara, David R., Lara, Primo N.
Publicado no Br J Haematol (2016)

A Phase I Pharmacodynamic Study of GTI-2040, an Antisense Oligonucleotide Against Ribonuclotide Reductase, in Acute Leukemias: A California Cancer Consortium Study

Por Kirschbaum, Mark H., Frankel, Paul, Synold, Timothy W., Xie, Zhiliang, Yen, Yun, Popplewell, Leslie, Chen, Robert, Aljitawi, Omar S., Tuscano, Joseph M., Chan, Kenneth K., Newman, Edward M.
Publicado no Leuk Lymphoma (2016)

Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: a California Cancer Consortium Trial

Por Mohrbacher, Ann M., Yang, Allen S., Groshen, Susan, Kummar, Shivaani, Gutierrez, Martin E., Kang, Min H., Tsao-Wei, Denice, Reynolds, C. Patrick, Newman, Edward M., Maurer, Barry J.
Publicado no Clin Cancer Res (2017)

Oral and intravenous pharmacokinetics of 5-fluoro-2’-deoxycytidine and THU in cynomolgus monkeys and humans

Por Holleran, Julianne L., Beumer, Jan H., McCormick, David L., Johnson, William D., Newman, Edward M., Doroshow, James H., Kummar, Shivaani, Covey, Joseph M., Davis, Myrtle, Eiseman, Julie L.
Publicado no Cancer Chemother Pharmacol (2015)

Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma

Por Kirschbaum, Mark, Frankel, Paul, Popplewell, Leslie, Zain, Jasmine, Delioukina, Maria, Pullarkat, Vinod, Matsuoka, Deron, Pulone, Bernadette, Rotter, Arnold J., Espinoza-Delgado, Igor, Nademanee, Auayporn, Forman, Stephen J., Gandara, David, Newman, Edward
Publicado em 2011

Pharmcodynamics (PD) and Pharmacokinetics (PK) of E7389 (Eribulin, Halichondrin B Analog) During a Phase I Trial in Patients with Advanced Solid Tumors: A California Cancer Consort...

Por Morgan, Robert J., Synold, Timothy W., Longmate, Jeffrey A., Quinn, David I, Gandara, David, Lenz, Heinz-Josef, Ruel, Christopher, Xi, Bixin, Lewis, Michael D., Colevas, A. Dimitrios, Doroshow, James, Newman, Edward M.
Publicado no Cancer Chemother Pharmacol (2015)

A Phase 1 Trial Dose Escalation Study of Tipifarnib on a Week-On, Week-Off Schedule in Relapsed, Refractory or High-Risk Myeloid Leukemia

Por Kirschbaum, Mark, Synold, Timothy, Stein, Anthony S., Tuscano, Joseph, Zain, Jasmine M., Popplewell, Leslie, Karanes, Chatchada, O'Donnell, Margaret R., Pulone, Bernadette, Rincon, Amalia, Wright, John, Frankel, Paul, Forman, Stephen J., Newman, Edward M.
Publicado em 2011

A phase I, pharmacokinetic, and pharmacodynamic evaluation of the DNA methyltransferase inhibitor 5-fuoro-2′-deoxycytidine, administered with tetrahydrouridine

Por Newman, Edward M., Morgan, Robert J., Kummar, Shivaani, Beumer, Jan H., Blanchard, M. Suzette, Ruel, Christopher, El-Khoueiry, Anthony B., Carroll, Mary I., Hou, Jessie M., Li, Chun, Lenz, Heinz J., Eiseman, Julie L., Doroshow, James H.
Publicado no Cancer Chemother Pharmacol (2015)

Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium Study

Por Shibata, Stephen I., Doroshow, James H., Frankel, Paul, Synold, Timothy W., Yen, Yun, Gandara, David R., Lenz, Heinz-Josef, Chow, Warren A., Leong, Lucille A., Lim, Dean, Margolin, Kim A., Morgan, Robert J., Somlo, George, Newman, Edward M.
Publicado em 2009

A Phase I Study of Veliparib in Combination with Metronomic Cyclophosphamide in Adults with Refractory Solid Tumors and Lymphomas

Por Kummar, Shivaani, Ji, Jiuping, Morgan, Robert, Lenz, Heinz-Josef, Puhalla, Shannon L., Belani, Chandra P., Gandara, David R., Allen, Deborah, Kiesel, Brian, Beumer, Jan H., Newman, Edward M., Rubinstein, Larry, Chen, Alice, Zhang, Yiping, Wang, Lihua, Kinders, Robert J., Parchment, Ralph E., Tomaszewski, Joseph E., Doroshow, James H.
Publicado em 2012

A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced stage solid cancers – A California C...

Por Chao, Joseph, Synold, Timothy W., Morgan, Robert J., Kunos, Charles, Longmate, Jeff, Lenz, Heinz-Josef, Lim, Dean, Shibata, Stephen, Chung, Vincent, Stoller, Ronald G., Belani, Chandra P., Gandara, David R., McNamara, Mark, Gitlitz, Barbara J., Lau, Derick H., Ramalingam, Suresh S., Davies, Angela, Espinoza-Delgado, Igor, Newman, Edward M., Yen, Yun
Publicado em 2011

Phase 1 Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study

Por Shibata, Stephen I, Chung, Vincent, Synold, Timothy, Longmate, Jeffrey, Suttle, A Benjamin, Ottesen, Lone H, Lenz, Heinz-Josef, Kummar, Shivaani, Harvey, R Donald, Hamilton, Anne, O’Neil, Bert, Sarantopoulos, John, LoRusso, Patricia, Rudek, Michelle A, Dowlati, Afshin, Mulkerin, Daniel, Belani, Chandra P., Gandhi, Leena, Lau, Cecilia, Ivy, S. Percy, Newman, Edward M.
Publicado em 2013

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline BRCA1- or BRCA2-Associated Metastatic Breast Cancer: California Cancer Cons...

Por Somlo, George, Frankel, Paul H., Arun, Banu K., Ma, Cynthia X., Garcia, Agustin A., Cigler, Tessa, Cream, Leah V., Harvey, Harold A., Sparano, Joseph A., Nanda, Rita, Chew, Helen K., Moynihan, Timothy J., Vahdat, Linda T., Goetz, Matthew P., Beumer, Jan H., Hurria, Arti, Mortimer, Joanne, Piekarz, Richard, Sand, Sharon, Herzog, Josef, Van Tongeren, Lily R., Ferry-Galow, Katherine V., Chen, Alice P., Ruel, Christopher, Newman, Edward M., Gandara, David R., Weitzel, Jeffrey N.
Publicado no Clin Cancer Res (2017)